Evidence map›Paper›PMID 42629401›Full record

ArticleJournal of exposure science & environmental epidemiology2026

Biomonitoring-based exposure assessment of phthalate and non-phthalate plasticizers: methodological insights from a 7-day consecutive sampling case study in Korea.

Jinhyun Kwon, Jin-Yeong Heo, Aram Lee, Hyo-Bang Moon, Kyungho Choi, Jeongim Park, Younglim Kho, Sungkyoon Kim

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of exposure science & environmental epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jinhyun KwonDepartment of Environmental Health Sciences, Graduate school of Public Health, Seoul National University, Seoul, Republic of Korea.
Jin-Yeong HeoDepartment of Health, Environment and Safety, Eulji University, Seongnam, Republic of Korea.
Aram LeeDepartment of Environmental Health Sciences, Soonchunhyang University, Asan, Republic of Korea.
Hyo-Bang MoonDepartment of Marine Science and Convergence Engineering, Hanyang University, Ansan, Republic of Korea.
Kyungho ChoiDepartment of Environmental Health Sciences, Graduate school of Public Health, Seoul National University, Seoul, Republic of Korea.
Jeongim ParkDepartment of Environmental Health Sciences, Soonchunhyang University, Asan, Republic of Korea.
Younglim KhoDepartment of Health, Environment and Safety, Eulji University, Seongnam, Republic of Korea.
Sungkyoon KimDepartment of Environmental Health Sciences, Graduate school of Public Health, Seoul National University, Seoul, Republic of Korea. ddram2@snu.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe increasing use of plasticizers as substitutes for heavily regulated phthalates raises concerns about human exposure. However, exposure patterns and suitable biomarkers for exposure assessment remain poorly understood.

objectiveThis study aimed to evaluate temporal variability of plasticizer metabolites in consecutively collected urine samples and to estimate exposure levels using toxicokinetic (TK) modeling.

methodsTwenty metabolites of six compounds, di-isononyl phthalate (DiNP), di-isodecyl phthalate (DiDP), di-ethylhexyl adipate (DEHA), di-ethylhexyl terephthalate (DEHTP), di-isononyl cyclohexane (DINCH), and tri-octyl trimellitate (TOTM) were quantified in 218 urine samples collected from six adults over one week. Intraclass correlation coefficients (ICC) and bivariate correlations were calculated to evaluate temporal variability across biomarkers. Time-activity diaries were used to identify exposure sources, and TK modeling was applied for biomonitoring-based reverse dosimetry.

resultsMetabolites of DiNP, DEHA, and DEHTP were frequently detected (>70%). First morning voids correlated moderately with daily average concentrations for frequently detected biomarkers (Spearman's ρ = 0.34-0.62, p ≤ 0.05). ICCs ranged from 0.16 to 0.73, with carboxylated metabolites demonstrating fair-to-good temporal stability (ICC = 0.57-0.68) for DiNP, DEHA and DINCH, while the hydroxylated metabolite showed the highest reproducibility for DEHTP (ICC = 0.62). Dietary intake, particularly processed foods, appeared to be the major exposure route, as concentration peaks of DiNP and DEHTP metabolites coincided with recorded dietary events. Daily intake estimates reconstructed from TK models under intermittent ingestion scenarios were generally lower than under continuous exposure assumptions, reflecting systematic differences. For most compounds, mass-balance approaches were comparable to TK model estimates, though DEHA showed a discrepancy attributable to the metabolite-specific model structure. IMPACT: Phthalate and non-phthalate substitutes increasingly replace heavily regulated phthalates, yet methodological frameworks for biomonitoring-based exposure assessment remain limited. We combined serial urine sampling, time-activity diaries, and toxicokinetic modeling as a case study for comprehensive exposure assessment. Key findings include: (1) secondary metabolites demonstrated fair-to-good temporal stability, while first morning void samples showed moderate correlations with daily exposure; (2) time-activity diaries identified potential dietary sources; and (3) toxicokinetic modeling accounting for realistic exposure scenarios demonstrated advantages over mass-balance approaches. These findings provide practical guidelines for individual-level assessments when environmental monitoring is limited.

Indexed as

Exposure biomarkerICCToxicokinetic modeling

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.